Stock Price
245.30
Daily Change
1.91 0.78%
Monthly
10.89%
Yearly
2.42%
Q3 Forecast
243.26

Peers Price Chg Day Year Date
Olympus 1,872.00 72.00 4.00% -25.99% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
CONMED 54.97 0.28 0.51% -25.89% Sep/05
Cooper Companies 68.09 0.09 0.13% -36.13% Sep/05
Dexcom 80.51 -0.25 -0.31% 17.11% Sep/05
Ecolab 273.56 -1.38 -0.50% 11.66% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Fortive 47.87 0.29 0.61% -32.27% Sep/05
Getinge 209.80 0.80 0.38% -3.98% Sep/05
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Haemonetics 54.38 0.30 0.55% -25.75% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
Idexx Laboratories 642.99 2.55 0.40% 36.13% Sep/05
Intuitive Surgical 466.86 12.34 2.72% -1.06% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Masimo 147.19 4.18 2.92% 31.97% Sep/05
3M 155.30 -0.22 -0.14% 20.62% Sep/05
Owens Minor 5.62 0.22 4.07% -63.72% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
ResMed 277.05 3.24 1.18% 13.23% Sep/05
Steris 245.30 1.91 0.78% 2.42% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
US400 3297 16.31 0.50% 12.16% Sep/05
US2000 2391 11.44 0.48% 14.33% Sep/05
US500 6481 -20.59 -0.32% 19.84% Sep/05

Steris traded at $245.30 this Friday September 5th, increasing $1.91 or 0.78 percent since the previous trading session. Looking back, over the last four weeks, Steris gained 10.89 percent. Over the last 12 months, its price rose by 2.42 percent. Looking ahead, we forecast Steris to be priced at 243.26 by the end of this quarter and at 237.26 in one year, according to Trading Economics global macro models projections and analysts expectations.